Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tilapia | 1 | 2017 | 1 | 0.630 |
Why?
|
| 1-Butanol | 1 | 2017 | 1 | 0.630 |
Why?
|
| Porins | 1 | 2017 | 2 | 0.630 |
Why?
|
| Metallothionein | 1 | 2017 | 4 | 0.630 |
Why?
|
| Clostridium | 1 | 2017 | 6 | 0.630 |
Why?
|
| Escherichia coli | 1 | 2017 | 81 | 0.600 |
Why?
|
| Drug Implants | 1 | 2016 | 10 | 0.580 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2016 | 5 | 0.580 |
Why?
|
| Doxorubicin | 1 | 2016 | 91 | 0.560 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 573 | 0.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2017 | 272 | 0.370 |
Why?
|
| Gene Expression Profiling | 6 | 2017 | 348 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 87 | 0.310 |
Why?
|
| Apoptosis | 3 | 2017 | 357 | 0.300 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 166 | 0.290 |
Why?
|
| Cell Line, Tumor | 7 | 2017 | 710 | 0.280 |
Why?
|
| Mitochondria | 2 | 2017 | 179 | 0.270 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 380 | 0.260 |
Why?
|
| Signal Transduction | 6 | 2017 | 693 | 0.230 |
Why?
|
| Rhabdoid Tumor | 2 | 2014 | 4 | 0.220 |
Why?
|
| Teratoma | 2 | 2014 | 12 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 122 | 0.220 |
Why?
|
| MicroRNAs | 2 | 2015 | 176 | 0.200 |
Why?
|
| Animals | 7 | 2017 | 7480 | 0.190 |
Why?
|
| Ubiquitination | 2 | 2017 | 14 | 0.190 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 36 | 0.180 |
Why?
|
| Mice, Nude | 2 | 2017 | 279 | 0.170 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2009 | 11 | 0.170 |
Why?
|
| Protein-Serine-Threonine Kinases | 2 | 2009 | 45 | 0.170 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 68 | 0.160 |
Why?
|
| Naphthoquinones | 1 | 2017 | 3 | 0.160 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 303 | 0.160 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 1 | 0.160 |
Why?
|
| Plant Lectins | 1 | 2017 | 2 | 0.160 |
Why?
|
| Genetic Enhancement | 1 | 2017 | 5 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2017 | 9 | 0.160 |
Why?
|
| Protein Engineering | 1 | 2017 | 17 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 38 | 0.160 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2016 | 5 | 0.150 |
Why?
|
| Histones | 1 | 2017 | 51 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2017 | 99 | 0.150 |
Why?
|
| Calcium Chloride | 1 | 2016 | 3 | 0.150 |
Why?
|
| Catalase | 1 | 2016 | 16 | 0.150 |
Why?
|
| Brain Neoplasms | 2 | 2014 | 582 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 93 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 64 | 0.140 |
Why?
|
| Peroxides | 1 | 2016 | 30 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 49 | 0.140 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 7 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2015 | 36 | 0.140 |
Why?
|
| Dermatomyositis | 1 | 2015 | 19 | 0.140 |
Why?
|
| Factor VII | 1 | 2015 | 5 | 0.140 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 15 | 0.140 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 17 | 0.140 |
Why?
|
| Fibrinogen | 1 | 2015 | 42 | 0.140 |
Why?
|
| Plasma Cells | 1 | 2015 | 15 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 100 | 0.140 |
Why?
|
| Factor VIII | 1 | 2015 | 19 | 0.140 |
Why?
|
| Oxygen | 1 | 2016 | 140 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 103 | 0.130 |
Why?
|
| RNA | 1 | 2015 | 88 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 179 | 0.130 |
Why?
|
| Humans | 15 | 2017 | 29549 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 497 | 0.110 |
Why?
|
| Nephroma, Mesoblastic | 1 | 2012 | 1 | 0.110 |
Why?
|
| Receptor, trkC | 1 | 2012 | 1 | 0.110 |
Why?
|
| Survivors | 1 | 2014 | 142 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 345 | 0.100 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 195 | 0.090 |
Why?
|
| Neoplasms | 1 | 2015 | 611 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2008 | 5 | 0.080 |
Why?
|
| Mice | 4 | 2017 | 2401 | 0.080 |
Why?
|
| Lysine | 2 | 2017 | 24 | 0.080 |
Why?
|
| Cell Survival | 2 | 2017 | 275 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 206 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2015 | 549 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 616 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2015 | 283 | 0.060 |
Why?
|
| Peptide Initiation Factors | 1 | 2003 | 2 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2015 | 914 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2003 | 71 | 0.060 |
Why?
|
| Brain | 1 | 2009 | 949 | 0.060 |
Why?
|
| Male | 6 | 2017 | 18203 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2017 | 593 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 1021 | 0.050 |
Why?
|
| Mutation | 2 | 2015 | 515 | 0.040 |
Why?
|
| Osteosarcoma | 1 | 2017 | 12 | 0.040 |
Why?
|
| Caspases | 1 | 2017 | 35 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2017 | 4 | 0.040 |
Why?
|
| Acetylation | 1 | 2017 | 14 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2017 | 71 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 38 | 0.040 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2016 | 3 | 0.040 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 4 | 0.040 |
Why?
|
| Cytosol | 1 | 2016 | 25 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 124 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 85 | 0.040 |
Why?
|
| Protein Transport | 1 | 2016 | 78 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 80 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 102 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2016 | 71 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 169 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 101 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2015 | 38 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2016 | 112 | 0.040 |
Why?
|
| Glucose | 1 | 2017 | 176 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 26 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 349 | 0.030 |
Why?
|
| Potassium Channels | 1 | 2015 | 20 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 90 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 305 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 80 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 465 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 230 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 145 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 378 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 199 | 0.030 |
Why?
|
| Female | 4 | 2015 | 18480 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 171 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2015 | 274 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 121 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 244 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 463 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 676 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 363 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 1 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 10 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2012 | 2 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2012 | 18 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 58 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 868 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2012 | 59 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 1185 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 1724 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 11 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 1241 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 13 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1234 | 0.020 |
Why?
|
| Child | 1 | 2015 | 2220 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 261 | 0.020 |
Why?
|
| Inbreeding | 1 | 2009 | 6 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 10 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2009 | 7 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2009 | 12 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 161 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2009 | 34 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 52 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 68 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2009 | 192 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 94 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 45 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 39 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 128 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2009 | 595 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 433 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 3750 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 192 | 0.020 |
Why?
|
| Cell Movement | 1 | 2008 | 163 | 0.020 |
Why?
|
| Infant | 1 | 2009 | 972 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 714 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3299 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 13 | 0.010 |
Why?
|
| Genes, ras | 1 | 2003 | 26 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 100 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 46 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2003 | 75 | 0.010 |
Why?
|
| Proteomics | 1 | 2003 | 91 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 296 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2003 | 228 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 9658 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 11220 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 438 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 821 | 0.010 |
Why?
|